Michael Good 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases 2017

Michael Good

Michael Good is an NHMRC Investigator Fellow at Griffith University. His research interests are in immunity and vaccine development for serious pathogens that predominantly affect underprivileged societies. He has developed candidate vaccines for the prevention of malaria and streptococcus/rheumatic heart disease and these have entered clinical trials. Following the COVID crisis, he is working with local and international doctors and scientists to develop an improved vaccine. He graduated MD PhD DSc from the University of Queensland and the Walter and Eliza Hall Institute of Medical Research/University of Melbourne and undertook postdoctoral training at the University of Queensland and at the National Institutes of Health in the USA. He was the inaugural Director of the Cooperative Research Centre for Vaccine Technology and the former Director of the Queensland Institute of Medical Research (2000-2010). He served as President of the Association of Australian Medical Research Institutes. From 2006-2012 he was Chair of the National Health and Medical Research Council of Australia. In 2008 he was made an Officer of the Order of Australia (AO), in 2009 he won the Australian Museum CSIRO Eureka Prize for Leadership in Science and in 2010 was named a Queensland Great, was awarded an NHMRC Australia Fellowship and a Doctorate of the University (Griffith). In 2011 he was named the Heart Foundation’s Researcher of the Year. Michael Good is a Fellow of the Australian Academy of Technological Sciences and Engineering and of the Australian Academy of Health and Medical Sciences. He is an International Honorary Fellow of the American Society for Tropical Medicine and Hygiene, a Fellow of the Royal Society of Biology and a Fellow of the American Academy of Microbiology.

Abstracts this author is presenting: